|
|
Post by oldfishtowner on May 9, 2023 15:38:42 GMT -5
4 cents loss per share. That's an earnings beat! 264 million shares outstanding according to the 2022 annual report. Undiluted earnings= ($6 million)/264 million shares outstanding= ($0.02)/share. 2 cent loss. Fully diluted is less. |
|
|
|
Post by akemp3000 on May 9, 2023 15:44:04 GMT -5
Can't recall a quarterly report with MNKD beating both EPS and revenue. Clearly moving toward profitability, hopefully this year!
|
|
|
|
Post by lookforgrowth on May 9, 2023 15:48:26 GMT -5
Is there a Shoutbox forum for the Earnings Conference call?
|
|
|
|
Post by mytakeonit on May 9, 2023 15:49:51 GMT -5
Ahhh ... probably next quarter is more like it.
But, that's mytakeonit
|
|
|
|
Post by liane on May 9, 2023 15:50:00 GMT -5
It's coming!
|
|
|
|
Post by oldfishtowner on May 9, 2023 15:53:49 GMT -5
4 cents loss per share. That's an earnings beat! 264 million shares outstanding according to the 2022 annual report. Undiluted earnings= ($6 million)/264 million shares outstanding= ($0.02)/share. 2 cent loss. Fully diluted is less. Sorry, you are correct. The 10Q gives a loss of 4 cents/share, but the net loss is not 6 million. It's quite a but higher. The 6 million must refer to something else. |
|
|
|
Post by JEvans on May 9, 2023 16:01:01 GMT -5
Long term deferred revenue is now up to $45.6M. Can you explain what defered revenue means ? |
|
|
|
Post by ktim on May 9, 2023 16:10:48 GMT -5
Deferred revenue growing is the piece I just don't understand given UTHR's claim during their call. UTHR claimed specialty pharmacies can't get their hands on enough product, yet we have deferred revenue. UTHR claimed MNKD is launching another production line to keep up with demand. It seems to me that if you are shipping everything you can make because pharmacies can't get their hands on enough product, then deferred revenue should at least be flat, not growing Q over Q. Anyone want to help me out and explain how these two statements can exist in the same universe? Note 10 is what you need to look at in the filing, though it doesn't give full clarity. I believe the long term deferred is likely due to MNKD receiving cash from UTHR to build out the manufacturing, but it is shown as deferred until the new capacity is actually put in use to produce product. |
|
|
|
Post by brentie on May 9, 2023 16:26:00 GMT -5
|
|
|
|
Post by anderson on May 9, 2023 16:51:27 GMT -5
Deferred revenue growing is the piece I just don't understand given UTHR's claim during their call. UTHR claimed specialty pharmacies can't get their hands on enough product, yet we have deferred revenue. UTHR claimed MNKD is launching another production line to keep up with demand. It seems to me that if you are shipping everything you can make because pharmacies can't get their hands on enough product, then deferred revenue should at least be flat, not growing Q over Q. Anyone want to help me out and explain how these two statements can exist in the same universe? UTHR building stock in their warehouse? |
|
|
|
Post by mytakeonit on May 9, 2023 16:58:50 GMT -5
JEvans - Deferred Revenue is revenue that's been deferred.  Ha! It means that you received $$$ in advance but you don't put it on your income statement until it is earned. Makes sense ? Okay, I made that up and you can google it if you really want to know. Ha! But, that's myaccountanttakeonit |
|
|
|
Post by ktim on May 9, 2023 16:59:38 GMT -5
Deferred revenue growing is the piece I just don't understand given UTHR's claim during their call. UTHR claimed specialty pharmacies can't get their hands on enough product, yet we have deferred revenue. UTHR claimed MNKD is launching another production line to keep up with demand. It seems to me that if you are shipping everything you can make because pharmacies can't get their hands on enough product, then deferred revenue should at least be flat, not growing Q over Q. Anyone want to help me out and explain how these two statements can exist in the same universe? UTHR building stock in their warehouse? There was a small increase in "deferred revenue - current" where I believe any deferred revenue based on shipments of Tyvaso DPI would be, since I would think that wouldn't be anticipated to be deferred for more than 12 months. The "deferred revenue - long term" increase is much larger, and what I'd suspect is due to being paid by UTHR to expand manufacturing capacity. The note defines this deferred revenue as not being expected to be recognized within next 12 months. |
|
|
|
Post by bthomas55ep on May 9, 2023 16:59:59 GMT -5
$48 Million Annual Run Rate end of 1st Quarter 2022. $164 Million Run Rate at the end of this quarter (Q1 2023). So, with the seemingly growth rate beginning to form at the bottom of the hockey stock 🏒 , the $4 share price ($1 Billion Market Valuation), in my view, is now more than fully justified. Would love to see 2Q knocking on the $50M+ door (projecting $200 Million annual revenue) and seeing revenue begin moving off the heel of the blade and start moving up the shaft. That will really allow the pps begin to move forward. Hopefully they won't issue too many of the 400 million new shares to counteract the revenue growth rate. Unless of course somebody wants to take a 10% equity stake at $3 to $5 Billion valuation. Let them own 100 Million of the new shares for $10 a piece 😀. GLTA |
|
|
|
Post by celo on May 9, 2023 17:06:39 GMT -5
UTHR building stock in their warehouse? There was a small increase in "deferred revenue - current" where I believe any deferred revenue based on shipments of Tyvaso DPI would be, since I would think that wouldn't be anticipated to be deferred for more than 12 months. The "deferred revenue - long term" increase is much larger, and what I'd suspect is due to being paid by UTHR to expand manufacturing capacity. The note defines this deferred revenue as not being expected to be recognized within next 12 months. Interesting that deferred revenue is listed as a liability. Accounts Receivable is an asset yet I have them as one and the same. Thanks ktim for the input |
|
|
|
Post by ktim on May 9, 2023 17:17:21 GMT -5
celo ... actually they are more like opposites. Accounts receivable is when you've done everything you need to do and just waiting to be paid for the work. Deferred revenue is when someone pays you upfront for work that you've not yet completed. Let's say you take your car into the repair shop and they say you have to pay $500 down before they start work. That $500 shows up as an asset in their bank once they deposit your check, but they haven't done the work, so there is an offsetting liability of $500 shown as "deferred revenue"... since they have that liability/obligation to do at least $500 worth of work for you. Small companies may not bother with that, but accountants require public companies to do this so that they can't game their earnings... like if the quarter would miss earnings estimates, they get some friendly client/customer to prepay for work/product that hasn't really been done or made. That would really juice earnings if they simply could recognize a prepayment as revenue and going straight to the bottom line since the expense associated with it hasn't yet occurred.
|
|
Ha!